Description

Bausch + Lomb, a prominent player in the eye health sector, reported its first-quarter results for 2025, showcasing a mixed financial and operational performance. Revenue at the company rose, reflecting a 5% constant currency growth across its reporting segments. The company’s Vision Care and Surgical segments performed particularly well, with 5% and 11% growth, respectively. This was driven by strong performances from its Daily SiHy contact lens and Blink franchise alongside premium intraocular lenses (IOLs).

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!